Adding saline irrigation to standard treatment for pleural infections
Official title: A Study to Evaluate the Efficacy of Pleural Space Saline Irrigation in Addition to Standard Intrapleural Thrombolytic Therapy in the Management of Empyema/Complicated Parapneumonic Effusion
Run by Mayo Clinic · NCT06434324 · Data updated 2026-11-12
This study is testing if adding saline irrigation through a chest tube to standard treatment can help people with pleural infections get better faster and spend less time in the hospital.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Status | Recruiting |
| Started | March 29, 2025 |
| Main results expected | December 2026 |
| Study ends | March 2027 |
| Registry record updated | March 30, 2026 |
| Trial ID | NCT06434324 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with purulent pleural fluid or specific pleural fluid analysis results indicating infection, who are starting intrapleural lytic therapy.
✕Probably not a fit
Patients with bleeding disorders, high INR, or those currently on systemic anticoagulation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effectiveness of saline irrigation through a chest tube in conjunction with standard intrapleural thrombolytic therapy for patients diagnosed with pleural space infections. The research focuses on improving pleural fluid evacuation and reducing hospital stays by potentially diluting bacteria and inflammatory factors in the pleural space. Patients will receive saline irrigation while undergoing standard antimicrobial therapy, and outcomes will be assessed based on clinical and radiographic improvements. The study is conducted at the Mayo Clinic, leveraging their expertise in interventional pulmonary care.
Why it matters
Potential benefit: If successful, this approach could lead to improved recovery times and reduced need for surgical interventions in patients with pleural infections.
How similar studies have gone: Previous studies, such as the MIST 2 trial, have shown success with similar approaches in managing pleural space infections.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria: * Purulent pleural fluid versus pleural fluid analysis demonstrating pH \<7.2, glucose \<60 mg/dL, positive Gram stain, or positive pleural fluid culture versus multiseptated pleural effusion with infection at top of differential diagnosis * Patients initiating intrapleural lytic therapy under the care of the Interventional Pulmonary consult service at Mayo Clinic in Rochester, MN Exclusion Criteria: * Unwillingness to give informed consent * Patients with known bleeding diathesis * Platelet count \<50,000 per μL * INR \>2.2 (of note, INR can be allowed to drift down or be reversed pharmacologically prior to initiation of intrapleural lytics/saline) * Current use of systemic anticoagulation or antiplatelet therapy without the ability to hold therapy for the recommended amount of time prior to an invasive procedure (aspirin monotherapy is acceptable) * Pregnant or nursing females, or females of child-bearing potential who decline a pregnancy test prior to enrollment * Incarcerated patients * Presence of ipsilateral bronchopleural fistula * Current or recent (within past 30 days) presence of tunneled pleural catheter on the same side as the current proven/suspected pleural space infection
Where it's running
-
Mayo Clinic in Rochester
Rochester, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Dagny Anderson, MD — Mayo Clinic
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pleural infection: comparing alteplase with DNase vs alteplase with Tyloxapol
This study tests whether adding DNase versus Tyloxapol to intrapleural alteplase helps clear pleural infection more effectively.
-
Flushing chest drains to improve outcomes in pleural infections
This study is testing if flushing chest drains with saline every six hours can help people with serious lung infections recover faster and spend less time in the hospital.
-
What the Mayo Clinic is learning from blood clot tests in allergic reactions
This study tests whether real-time blood clotting markers can help understand and predict the severity of allergic reactions and anaphylaxis in patients 12 and older.
-
Atrial Arrhythmia AI-Powered Post-Ablation Predictor Pilot
This pilot study tests whether AI models using non-invasive heart-mapping data can predict how patients with atrial arrhythmias respond after ablation.
-
A Community Approach to Boost Cervical Cancer Screening for Hispanic and East African Immigrant Women
The study tests a community-based program that offers self-collection HPV tests and information to Hispanic and East African immigrant women to see if screening rates improve.
-
Point-of-care AI spectroscopy test to triage vulvar lesions
This pilot study tests whether a handheld AI-powered spectroscopy device can help triage vulvar lesions in adults who are planning surgical removal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.